Top

Published in:

Open Access 01-12-2020 | Artificial Intelligence | Review

FRAX: re-adjust or re-think

Author: Yasser El Miedany

Published in: Archives of Osteoporosis | Issue 1/2020

Abstract

Since its development in 2008, FRAX has booked its place in the standard day to day management of osteoporosis. The FRAX tool has been appreciated for its simplicity and applicability for use in primary care, but criticised for the same reason, as it does not take into account exposure response. To address some of these limitations, relatively simple arithmetic procedures have been proposed to be applied to the conventional FRAX estimates of hip and major fracture probabilities aiming at adjustment of the probability assessment. However, as the list of these adjustments got longer, this has reflected on its implementation in the standard practice and gave FRAX a patchy look. Consequently, raises the need to re-think of the current FRAX and whether a second generation of the tool is required to address the perceived limitations of the original FRAX. This article will discuss both point of views of re-adjustment and re-thinking.

Kanis JA, Oden A, Johnell O, Jonsson B, de Laet C, Dawson A (2001) The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int 12:417–427PubMed

Kanis JA, Borgstrom F, De Laet C, Johansson H et al (2005) Assessment of fracture risk. Osteoporos Int 16:581–589PubMed

Kanis JA, Odén A, McCloskey EV et al (2012) A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int 23:2239–2256PubMedPubMedCentral

Cauley JA, Chalhoub D, Kassem AM, Fuleihan Gel-H (2014) Geographic and ethnic disparities in osteoporotic fractures. Nat Rev Endocrinol 10:338–351PubMed

Kanis JA, Johansson H, Oden A et al (2014) Worldwide uptake of FRAX. Arch Osteoporos 9:166PubMed

Kanis JA on behalf of the World Health Organization Scientific Group (2008) Assessment of osteoporosis at the primary healthcare level. Technical Report. WHO Collaborating Centre, University of Sheffield, UK. http://www.shef.ac.uk/FRAX/index .htm. Accessed 18^th July 2020

Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008) FRAX™ and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19:385–397PubMedPubMedCentral

Johansson H, Azizieh F, Al Ali N, Alessa T, Harvey NC, McCloskey E et al (2017) FRAX- vs. T-score-based intervention thresholds for osteoporosis. Osteoporos Int 28:3099–3105PubMedPubMedCentral

Kanis JA, Johansson H, Harvey NC, McCloskey EV (2018) A brief history of FRAX. Arch Osteoporos 13(1):118PubMedPubMedCentral

10.

Brennan SL, Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA (2014) FRAX provides robust fracture prediction regardless of socioeconomic status. Osteoporos Int 25(1):61–69PubMed

11.

Kanis JA, Harvey NC, Cyrus Cooper C, Johansson H, Odén A, McCloskey EV et al (2016) A systematic review of intervention thresholds based on FRAX. A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos 11(1):25PubMedPubMedCentral

12.

Leslie W (2019) FRAX: a coming of age. Osteoporos Int 30:1–2PubMed

13.

Kanis JA, Hans D, Cooper C et al (2011) Interpretation and use of FRAX in clinical practice. Osteoporos Int 22:2395–2411PubMed

14.

Johansson H, Odén A, McCloskey EV, Kanis JA (2014) Mild morphometric vertebral fractures predict vertebral fractures but not non-vertebral fractures. Osteoporos Int 25:235–241PubMed

15.

Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2000) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993–1000PubMed

16.

Kanis JA, Johnell O, Oden A, Johansson H, De Laet C, Eisman JA et al (2005) Smoking and fracture risk: a meta-analysis. Osteoporos Int 16:155–162PubMed

17.

Kanis JA, Johansson H, Johnell O, Oden A, De Laet C, Eisman JA et al (2005) Alcohol intake as a risk factor for fracture. Osteoporos Int 16:737–742PubMed

18.

Johansson H, Siggeirsdottir K, Harvey NC, Oden A, Gudnason V, McCloskey E et al (2017) Imminent risk of fracture after fracture. Osteoporos Int 28(3):775–780PubMed

19.

Giangregorio LM, Leslie WD, Manitoba Bone Density P (2010) Time since prior fracture is a risk modifier for 10-year osteoporotic fractures. J Bone Miner Res 25(6):1400–1405PubMed

20.

Roux C, Briot K (2017) Imminent fracture risk. Osteoporos Int 28(6):1765–1769PubMed

21.

Kanis JA, Harvey NC, Johansson H, Liu E, Vandenput L, Lorentzon M, Leslie WD, McCloskey EV (2020) A decade of FRAX: how has it changed the management of osteoporosis? Aging Clin Exp Res 32(2):187–196PubMed

22.

Kanis JA, Johansson H, Oden A, McCloskey EV (2011) Guidance for the adjustment of FRAX according to the dose of glucocorticoids. Osteoporos Int 22:809–816PubMed

23.

Johansson H, Kanis JA, Odén A, Leslie WD, Fujiwara S, Glüer CC, Kroger H, LaCroix AZ, Lau E, Melton LJ III, Eisman JA, O’Neill TW, Goltzman D, Reid DM, McCloskey E (2014) Impact of femoral neck and lumbar spine BMD discordances on FRAX probabilities in women: a meta-analysis of international cohorts. Calcif Tissue Int 95:428–435PubMedPubMedCentral

24.

Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA (2011) Spine-hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement. Osteoporos Int 22:839–847PubMed

25.

Leslie WD, Johansson H, Kanis JA, Lamy O, Oden A, McCloskey EV, Hans D (2014) Lumbar spine texture enhances 10-year fracture probability assessment. Osteoporos Int 25:2271–2277PubMed

26.

Leslie WD, Shevroja E, Johansson H, McCloskey EV, Harvey NC, Kanis JA, Hans D (2018) Risk-equivalent T-score adjustment using lumbar spine trabecular bone score (TBS): the Manitoba BMD Registry. Osteoporos Int 29:751–758PubMedPubMedCentral

27.

McCloskey EV, Oden A, Harvey NC et al (2015) Adjusting fracture probability by trabecular bone score. Calcif Tissue Int 96:500–509PubMed

28.

McCloskey EV, Odén A, Harvey NC et al (2016) A meta-analysis of trabecular bone score in fracture risk prediction and its dependence on FRAX. J Bone Miner Res 31:940–948PubMed

29.

Leslie WD, Lix LM, Morin SN et al (2015) Adjusting hip fracture probability in men and women using hip axis length: the Manitoba Bone Density Database. J Clin Densitom 19:326–331PubMed

30.

Masud T, Binkley N, Boonen S, Hannan MT, on behalf of the FRAX Position Conference members (2011) Can falls and frailty be used in FRAX? J Clin Densitom 14:194–204PubMed

31.

Johansson H, Odén A, Lorentzon M, McCloskey E, Kanis JA, Harvey NC, Karlsson MK, Mellström D (2015) Is the Swedish FRAX model appropriate for immigrants to Sweden? Osteoporos Int 26:2617–2622PubMed

32.

Leslie WD, Rubin MR, Schwartz AZ, Kanis JA (2012) Perspective: diabetes and bone. J Bone Miner Res 27:2231–2237PubMed

33.

Leslie WD, Johansson H, McCloskey EV, Harvey NC, Kanis JA, Hans D (2018) Comparison of methods for improving fracture risk assessment in diabetes: the Manitoba BMD Registry. J Bone Miner Res 33(11):1923–1930PubMedPubMedCentral

34.

Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, de Santis M, Fossati N, Gross T, Henry AM, Joniau S, Lam TB, Mason MD, Matveev VB, Moldovan PC, van den Bergh RCN, van den Broeck T, van der Poel HG, van der Kwast TH, Rouvière O, Schoots IG, Wiegel T, Cornford P (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: Screening, diagnosis, and local treatment with curative intent. Eur Urol 71(4):618–629PubMed

35.

Whitlock R, Leslie WD, Shaw J et al (2019) The Fracture Risk Assessment Tool (FRAX®) predicts fracture risk in patients with chronic kidney disease. Kidney Int 95:447–454PubMed

36.

Giangregorio LM, Leslie WD, Manitoba Bone Density Program (2010) Time since prior fracture is a risk modifier for 10-year osteoporotic fractures. J Bone Miner Res 25:1400–1405PubMed

37.

Balasubramanian A, Zhang J, Chen L, Wenkert D, Daigle SG, Grauer A, Curtis JR (2019) Risk of subsequent fracture after prior fracture among older women. Osteoporos Int 30:79–92PubMed

38.

Johnell O, Oden A, Caulin F, Kanis JA (2001) Acute and long-term increase in fracture risk after hospitalization for vertebral fracture. Osteoporos Int 12:207–214PubMed

39.

Johnell O, Kanis JA, Oden A et al (2004) Fracture risk following an osteoporotic fracture. Osteoporos Int 15:175–179PubMed

40.

Kanis JA, Johansson H, Odén A, Harvey NC, Gudnason V, Sanders KM, Sigurdsson G, Siggeirsdottir K, Fitzpatrick LA, Borgström F, McCloskey EV (2018) Characteristics of recurrent fractures. Osteoporos Int 29:1747–1757PubMedPubMedCentral

41.

Kanis JA, Harvey NC, McCloskey E, Bruyère O, Veronese N, Lorentzon M, Cooper C, Rizzoli R, Adib G, al-Daghri N, Campusano C, Chandran M, Dawson-Hughes B, Javaid K, Jiwa F, Johansson H, Lee JK, Liu E, Messina D, Mkinsi O, Pinto D, Prieto-Alhambra D, Saag K, Xia W, Zakraoui L, Reginster JY (2020) Algorithm for the management of patients at low/middle/high risk of osteoporotic fracture: a global perspective. Osteoporos Int 31:1–12PubMed

42.

Leslie W, Morin S (2020) New developments in fracture risk assessment for current osteoporosis reports. Curr Osteoporos Rep 18:115–129PubMed

43.

Leslie WD, Shevroja E, Johansson H, McCloskey EV, Harvey NC, Kanis JA, Hans D (2018) Risk-equivalent T-score adjustment for using lumbar spine trabecular bone score (TBS): the Manitoba BMD Registry. Osteoporos Int 29:751–758PubMedPubMedCentral

44.

Martineau P, Leslie WD, Johansson H, Harvey NC, McCloskey EV, Hans D et al (2018) In which patients does lumbar spine trabecular bone score (TBS) have the largest effect? Bone 113:161–168PubMedPubMedCentral

45.

Tomkinson A, Reeve J, Shaw RW, Noble BS (1997) The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J Clin Endocrinol Metab 82(9):3128–3135PubMed

46.

Clarke BL, Khosla S (2010) Physiology of bone loss. Radiol Clin N Am 48(3):483–495PubMed

47.

Smith MD, Ross W, Ahern MJ (2001) Missing a therapeutic window of opportunity: an audit of patients attending a tertiary teaching hospital with potentially osteoporotic hip and wrist fractures. J Rheumatol 28:2504–2508PubMed

48.

El Miedany YM, el Gaafary S, el Baddini MA (1999) Osteoporosis in older adults with non-insulin-dependent diabetes mellitus: is it sex related? Clin Exp Rheumatol 17(5):561–567PubMed

49.

Ferrari SL, Abrahamsen B, Napoli N, Akesson K, Chandran M, Eastell R et al (2018) Diagnosis and management of bone fragility in diabetes: an emerging challenge. Osteoporos Int 29(12):2585–2596PubMedPubMedCentral

50.

Leslie WD, Johansson H, McCloskey EV, Harvey NC, Kanis JA, Hans D (2018) Comparison ofmethods for improving fracture risk assessment in diabetes: the Manitoba BMD Registry. J Bone Miner Res 33(11):1923–1930PubMedPubMedCentral

51.

McClung MR, Geusens P, Miller PD et al (2001) Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med 344:333–340

52.

McCloskey EV, Johansson H, Oden A et al (2009) Ten-year fracture probability identifies women who will benefit from clodronate therapy additional results from a double-blind, placebo-controlled randomised study. Osteoporos Int 20(5):811–817

53.

El Miedany Y, El Gaafary M, Toth M, Hegazi M, El Aroussy N, Hassan W, Almedany S, Nasr A, Bahlas S (2020) Therapeutic approaches to osteosarcopenia: denosumab effect on falls risk, physical performance and walking speed. Ann Rheum Dis 79(suppl 1):193

54.

El Miedany Y, Toth M (2011) Osteoporosis, fracture prevention and falls risk assessment –closing the gap between treatment guidelines and clinical practice. Eur Musculoskelet Rev 6(1):14–17

55.

Wehren LE, Siris ES (2004) Beyond bone mineral density: can existing clinical risk assessment instruments identify women at increased risk of osteoporosis? J Intern Med 256:375–380PubMed

56.

Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J, Burckhardt P, Cooper C, Christiansen C, Cummings S, Eisman JA, Fujiwara S, Glüer C, Goltzman D, Hans D, Krieg MA, La Croix A, McCloskey E, Mellstrom D, Melton LJ 3rd, Pols H, Reeve J, Sanders K, Schott AM, Silman A, Torgerson D, van Staa T, Watts NB, Yoshimura N (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18:1033–1046

57.

Rubin KH, Friis-Holmberg T, Hermann AP, Abrahamsen B, Brixen K (2013) Risk assessment tools to identify women with increased risk of osteoporotic fracture: complexity or simplicity? A systematic review. J Bone Miner Res 28(8):1701–1717PubMed

58.

Leslie WD, Manitoba Bone Density Program C (2008) Absolute fracture risk reporting in clinical practice: a physician-centered survey. Osteoporos Int 19(4):459–463PubMed

59.

Leslie WD, Morin S, Lix LM (2010) A before-and-after study of fracture risk reporting and osteoporosis treatment initiation. Ann Intern Med 153(9):580–586PubMed

60.

Leslie WD, Seeman E, Morin SN, Lix LM, Majumdar SR (2018) The diagnostic threshold for osteoporosis impedes fracture prevention in women at high risk for fracture: a registry-based cohort study. Bone 114:298–303PubMed

61.

Shepstone L, Lenaghan E, Cooper C, Clarke S, Fong-Soe-Khioe R, Fordham R et al (2018) Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial. Lancet 391(10122):741–747PubMed

62.

Rubin KH, Rothmann MJ, Holmberg T, Hoiberg M, Moller S, Barkmann R et al (2018) Effectiveness of a two-step population-based osteoporosis screening program using FRAX: the randomized Risk-stratified Osteoporosis Strategy Evaluation (ROSE) study. Osteoporos Int 29(3):567–578PubMed

63.

Merlijn T, Swart KM, van Schoor NM, Heymans MW, van der Zwaard BC, van der Heijden AA et al (2019) The effect of a screening and treatment program for the prevention of fractures in older women: a randomized pragmatic trial. J Bone Miner Res 34(11):1993–2000PubMedPubMedCentral

64.

Cannada LK, Hill BW (2014) Osteoporotic hip and spine fractures: a current review. Geriatr Orthop Surg Rehabil 5(4):207–212PubMedPubMedCentral

65.

Crandall CJ, Larson J, LaCroix A, Cauley JA, LeBoff MS, Li W et al (2019) Predicting fracture risk in younger postmenopausal women: comparison of the Garvan and FRAX risk calculators in the Women’s Health Initiative Study. J Gen Intern Med 34(2):235–242PubMed

66.

Crandall CJ, Schousboe JT, Morin SN, Lix LM, Leslie W (2019) Performance of FRAX and FRAX-based treatment thresholds in women aged 40 years and older: the Manitoba BMD Registry. J Bone Miner Res 34(8):1419–1427PubMed

67.

Uusi-Rasi K, Semanick LM, Zanchetta JR, Bogado CE, Eriksen EF, Sato M et al (2005) Effects of teriparatide [rhPTH (1–34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women. Bone. 36:948–958PubMed

68.

Saag KG, Agnusdei D, Hans D, Kohlmeier LA, Krohn KD, Leib ES, MacLaughlin EJ, Alam J, Simonelli C, Taylor KA, Marcus R (2016) Trabecular bone score in patients with chronic glucocorticoid-induced osteoporosis treated with alendronate or teriparatide. Arthritis Rheum 68(9):2122–2128

69.

Ferizi U, Besser H, Hysi P, Jacobs J, Rajapakse CS, Chen C, et al. (2018) Artificial intelligence applied to osteoporosis: a performance comparison of machine learning algorithms in predicting fragility fractures from MRI data. J Magn Reson Imaging

70.

Ho-Le TP, Center JR, Eisman JA, Nguyen TV, Nguyen HT (2017) Prediction of hip fracture in postmenopausal women using artificial neural network approach. Conf Proc IEEE Eng Med Biol Soc 2017:4207–4210

71.

Kruse C, Eiken P, Vestergaard P (2017) Machine learning principles can improve hip fracture prediction. Calcif Tissue Int 100(4):348–360PubMed

72.

Kim DW, Kim H, Nam W, Kim HJ, Cha IH (2018) Machine learning to predict the occurrence of bisphosphonate-related osteonecrosis of the jaw associated with dental extraction: a preliminary report. Bone. 116:207–214PubMed

73.

Kruse C, Eiken P, Vestergaard P (2017) Clinical fracture risk evaluated by hierarchical agglomerative clustering. Osteoporos Int 28(3):819–832PubMed

74.

Ferizi U, Honig S, Chang G (2019) Artificial intelligence, osteoporosis and fragility fractures. Curr Opin Rheumatol 31(4):368–375PubMedPubMedCentral

Title: FRAX: re-adjust or re-think
Author: Yasser El Miedany
Publication date: 01-12-2020
Publisher: Springer London
Keywords: Artificial Intelligence
Glucocorticoid
Osteoporosis
Osteoporosis
Published in: Archives of Osteoporosis / Issue 1/2020
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI: https://doi.org/10.1007/s11657-020-00827-z

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

FRAX: re-adjust or re-think

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2020

Do patients that fracture with normal DXA-measured BMD have normal bone?

The incidence and risk factors for adjacent vertebral fractures in community-dwelling people with prevalent vertebral fracture: the 3rd and 4th survey of the ROAD study

Experience gained from the implementation of the fracture liaison service in Greece

Cumulative network meta-analyses, practice guidelines, and actual prescriptions for postmenopausal osteoporosis: a meta-epidemiological study

Bone mineral density in young adults: the influence of vitamin D status, biochemical indicators, physical activity and body composition

Best Practice Framework of Fracture Liaison Services in Spain and their coordination with Primary Care